JAY BAKUL SHAH to Humans
This is a "connection" page, showing publications JAY BAKUL SHAH has written about Humans.
Connection Strength
0.126
-
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer. Gynecol Oncol. 2018 01; 148(1):181-188.
Score: 0.012
-
Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy. Urology. 2014 Nov; 84(5):1147-51.
Score: 0.009
-
Strategies for optimizing bacillus Calmette-Gu?rin. Urol Clin North Am. 2013 May; 40(2):211-8.
Score: 0.008
-
New strategies in muscle-invasive bladder cancer: on the road to personalized medicine. Clin Cancer Res. 2011 May 01; 17(9):2608-12.
Score: 0.007
-
Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special? Cancer. 2011 Mar 01; 117(5):882-3.
Score: 0.007
-
In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma. Expert Rev Anticancer Ther. 2010 Jun; 10(6):837-42.
Score: 0.007
-
Clinical trials: nationally representative data in urology. Nat Rev Urol. 2009 Jul; 6(7):354-5.
Score: 0.007
-
Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol. 2008 Jan; 179(1):136-40.
Score: 0.006
-
Water under the bridge: 5-year outcomes after percutaneous ablation of obstructing parapelvic renal cysts. J Endourol. 2007 Oct; 21(10):1167-70.
Score: 0.006
-
New treatments for superficial bladder cancer. Curr Oncol Rep. 2006 May; 8(3):201-5.
Score: 0.005
-
PSA updated: still relevant in the new millennium? Eur Urol. 2005 Apr; 47(4):427-32.
Score: 0.005
-
Novel therapeutics in the treatment of bladder cancer. Curr Opin Urol. 2004 Sep; 14(5):287-93.
Score: 0.005
-
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy. Clin Cancer Res. 2023 05 15; 29(10):1969-1983.
Score: 0.004
-
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76.
Score: 0.002
-
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2015 Feb; 67(2):241-9.
Score: 0.002
-
Clinical outcomes of cT1 micropapillary bladder cancer. J Urol. 2015 Apr; 193(4):1129-34.
Score: 0.002
-
Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med. 2014 Sep; 174(9):1450-9.
Score: 0.002
-
Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa. J Urol. 2013 Oct; 190(4):1404-9.
Score: 0.002
-
Current preclinical models for the advancement of translational bladder cancer research. Mol Cancer Ther. 2013 Feb; 12(2):121-30.
Score: 0.002
-
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis. Cell Death Differ. 2013 Mar; 20(3):382-95.
Score: 0.002
-
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2013 Jan; 63(1):36-44.
Score: 0.002
-
Demographic analysis of randomized controlled trials in bladder cancer. BJU Int. 2013 Mar; 111(3):419-26.
Score: 0.002
-
Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. 2013 Aug; 64(2):307-13.
Score: 0.002
-
p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS One. 2012; 7(1):e30206.
Score: 0.002
-
Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): a video-based illustration of technique, results, and unmet patient selection needs. BJU Int. 2011 Sep; 108(6 Pt 2):993-8.
Score: 0.002
-
Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells. Cancer Biol Ther. 2010 Nov 01; 10(9):885-92.
Score: 0.002
-
A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer. 2010 Oct 01; 116(19):4513-9.
Score: 0.002
-
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev. 2009 Dec; 28(3-4):335-44.
Score: 0.002
-
Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer. Urol Oncol. 2009 Nov-Dec; 27(6):585-91.
Score: 0.002
-
Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer. Urology. 2007 Oct; 70(4):706-10.
Score: 0.001
-
Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy. J Urol. 2006 May; 175(5):1663-7; discussion 1667.
Score: 0.001
-
Does year of radical prostatectomy independently predict outcome in prostate cancer? Urology. 2006 Feb; 67(2):368-72.
Score: 0.001
-
Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005 Sep; 174(3):827-34.
Score: 0.001